This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n16http://linked.opendata.cz/resource/drugbank/drug/DB02203/identifier/pdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02203/identifier/kegg-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02203/identifier/pubchem-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02203/identifier/pubchem-substance/
n6http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB02203/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02203/identifier/chemspider/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02203/identifier/chebi/

Statements

Subject Item
n2:DB02203
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02203 n7:DB02203
dcterms:title
Acetone Cyanohydrin
adms:identifier
n10:6166 n11:DB02203 n12:15348 n13:6406 n14:46505571 n15:C02659 n16:CNH
n3:synthesisReference
Wilhelm Gruber, Guenter Schroeder, "Method for making .alpha.-hydroxy-isobutyramide from acetone cyanohydrin." U.S. Patent US4018829, issued December, 1973.
n3:IUPAC-Name
n4:271B47A7-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B47AD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B47AC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B47A9-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B47AA-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B47AB-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B47A5-363D-11E5-9242-09173F13E4C5 n4:271B47BD-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B47A6-363D-11E5-9242-09173F13E4C5 n4:271B47A3-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B47A4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B47B3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B47B4-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B47AE-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B47AF-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B47B1-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B47B0-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B47B2-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
75-86-5
n3:Bioavailability
n4:271B47B9-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n4:271B47BF-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B47BB-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B47BC-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B47BE-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B47B8-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B47B7-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B47BA-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B47A8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B47B5-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B47B6-363D-11E5-9242-09173F13E4C5